WANY
AVNS

Wealthspire Advisors (New York)’s Avanos Medical AVNS Stock Holding History

Wealthspire Advisors (New York)’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-84
Closed -$972 – 1184
2025
Q3 		$972 Buy
+84
New +$984 ﹤0.01% 2748
2019
Q1 		– Sell
-29
Closed -$1K – 107
2018
Q4 		$1K Buy
+29
New +$1.52K ﹤0.01% 783

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wealthspire Advisors (New York)'s AVNS Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of Avanos Medical (AVNS) in Q4 2025, closing a stake of 84 shares — an estimated $972 sold.

Wealthspire Advisors (New York) first reported a position in AVNS in Q4 2018 and held it in 2 quarters. The position peaked at $1K in Q4 2018. 274 funds tracked by Wall St. Rank hold AVNS as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining Avanos Medical position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 84 Avanos Medical shares in Q4 2025, an estimated $972.
  • Wealthspire Advisors (New York) first reported a position in Avanos Medical in Q4 2018 and held it in 2 quarters.
  • Wealthspire Advisors (New York)'s Avanos Medical position peaked at $1K in Q4 2018.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.